High Mark Wealth Management LLC Biomarin Pharmaceutical Inc Transaction History
High Mark Wealth Management LLC
- $182 Million
- Q3 2024
A detailed history of High Mark Wealth Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, High Mark Wealth Management LLC holds 75 shares of BMRN stock, worth $4,995. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75
Previous 75
-0.0%
Holding current value
$4,995
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BMRN
# of Institutions
627Shares Held
183MCall Options Held
1.63MPut Options Held
1.2M-
Black Rock Inc. New York, NY22.7MShares$1.51 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.27 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.8MShares$1.25 Billion1.14% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$928 Million0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$646 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.4B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...